American Century Companies’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMT
WP
SCM
CP
AAA
GPP
American Century Companies's SGMT Position: Q2 2026 in Review
American Century Companies increased its Sagimet Biosciences (SGMT) stake by 26% in Q2 2026, buying an estimated $107K and bringing the position to 76,095 shares worth $588K. The position accounts for ﹤0.01% of the portfolio, ranked #2550.
American Century Companies first reported a position in SGMT in Q4 2024 and has held it in 7 quarters since. 110 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.
- American Century Companies held 76,095 shares of Sagimet Biosciences worth $588K as of Q2 2026.
- American Century Companies bought 15,726 Sagimet Biosciences shares in Q2 2026, an estimated $107K.
- Sagimet Biosciences made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2550 holding.
- American Century Companies first reported a position in Sagimet Biosciences in Q4 2024 and has held it in 7 quarters since.
- 110 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.